Journal article

Publication year: 2017

Pages: 88437-88452

Journal: Oncotarget

Volume number: 8

Issue number: 51

Open access status: Gold

DOI Link: https://doi.org/10.18632/oncotarget.18177

URL: http://nbn-resolving.de/urn:nbn:de:hebis:26-opus-138839

Publisher: Impact Journals

Abstract: 

The Hippo pathway regulates organ size, growth and comprises several tumor related factors, including the oncoprotein YAP1 and the tumor suppressor RASSF1A. RASSF1A is frequently epigenetically inactivated in cancer. In our study, we analyzed the effect of RASSF1A on the function of YAP1. Expression of YAP1 resulted in the downregulation of several tumor suppressor genes and induction of S-phase. Co-expression with RASSF1A normalized the expression levels of these tumor suppressors and induced a G0-G1 arrest and apoptosis. This effect was associated with the reduction of MDM2 and the increase of p53. These data suggest that the tumor suppressor RASSF1A inhibits the oncogenic potential of YAP1. Additionally, we could show that ANKRD1 is a YAP1 target gene that is induced by RASSF1A. Further analysis revealed that ANKRD1 is epigenetically inactivated in human cancer. ANKRD1 expression induced the expression of TP53 as well as BAX and CDKN1A and reduced colony formation of cancer cells. We found that ANKRD1 interacts with p53 and is involved in the destabilization of MDM2. Additionally, our data indicate that the tumor-suppressive effect of ANKRD1 depends on the presence of p53. These results suggest that ANKRD1 is a tumor-suppressive downstream target of the Hippo pathway that is epigenetically silenced in human cancer.

Harvard Citation style: Jiménez, A., Traum, A., Boettger, T., Hackstein, H., Richter, A. and Dammann, R. (2017) The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth, Oncotarget, 8(51), pp. 88437-88452. https://doi.org/10.18632/oncotarget.18177

APA Citation style: Jiménez, A., Traum, A., Boettger, T., Hackstein, H., Richter, A., & Dammann, R. (2017). The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth. Oncotarget. 8(51), 88437-88452. https://doi.org/10.18632/oncotarget.18177